Captrust Financial Advisors Adaptive Biotechnologies Corp Transaction History

Captrust Financial Advisors

$33 Billion
Q3 2024

A detailed history of Captrust Financial Advisors transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Captrust Financial Advisors holds 12,930 shares of ADPT stock, worth $82,622. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,930

Previous 11,313 14.29%

Holding current value

$82,622

Previous $40,000 65.0%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$3.37 - $5.12 $5,449 - $8,279	1,617 Added 14.29%	12,930 $66,000
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $2,384 - $4,035	1,019 Added 9.9%	11,313 $40,000
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $4,896 - $8,160	-1,700 Reduced 14.17%	10,294 $33,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $1,864 - $2,872	539 Added 4.71%	11,994 $58,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $3,751 - $6,245	-740 Reduced 6.07%	11,455 $62,000
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $427 - $605	69 Added 0.57%	12,195 $81,000
Q1 2023 May 15, 2023	BUY	$7.8 - $10.11 $94,582 - $122,593	12,126 New	12,126 $107,000
Q3 2022 Nov 16, 2022	BUY	$6.5 - $12.67 $72,553 - $141,422	11,162 Added 966.41%	12,317 $88,000
Q2 2022 Aug 23, 2022	SELL	$6.4 - $14.73 $1,004 - $2,312	-157 Reduced 11.97%	1,155 $9,000
Q2 2022 Aug 16, 2022	SELL	$6.4 - $14.73 $1,382 - $3,181	-216 Reduced 14.14%	1,312 $11,000
Q1 2022 May 16, 2022	BUY	$10.12 - $28.9 $7,670 - $21,906	758 Added 98.44%	1,528 $21,000
Q4 2021 Feb 14, 2022	BUY	$25.17 - $36.85 $4,530 - $6,633	180 Added 30.51%	770 $22,000
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $28,031 - $38,793	-870 Reduced 59.59%	590 $24,000
Q1 2021 May 17, 2021	BUY	$37.26 - $67.74 $10,060 - $18,289	270 Added 22.69%	1,460 $59,000
Q4 2020 Feb 16, 2021	SELL	$45.01 - $65.47 $270 - $392	-6 Reduced 0.5%	1,190 $70,000
Q3 2020 Nov 17, 2020	BUY	$35.79 - $48.81 $42,804 - $58,376	1,196 New	1,196 $59,000

Others Institutions Holding ADPT

# of Institutions

202

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $913M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.

Account

Captrust Financial Advisors Adaptive Biotechnologies Corp Transaction History